Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Russell, Beth"'
Autor:
Beckmann K; UniSA Cancer Research Institute, University of South Australia, Adelaide, Australia. Kerri.beckmann@kcl.ac.uk.; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK. Kerri.beckmann@kcl.ac.uk., Russell B; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK., Josephs D; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK., Garmo H; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK.; Regional Cancer Centre Uppsala, Uppsala University Hospital, Uppsala, Sweden., Haggstrom C; Department of Biobank Research, Umea University, Umea, Sweden.; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden., Holmberg L; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK.; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden., Stattin P; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden., Van Hemelrijck M; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK.; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Adolfsson J; CLINTEC-department, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
BMC cancer [BMC Cancer] 2019 Jun 21; Vol. 19 (1), pp. 612. Date of Electronic Publication: 2019 Jun 21.
Autor:
Russell, Beth1 beth.russell@kcl.ac.uk, Garmo, Hans1,2, Beckmann, Kerri1,3, Stattin, Pär4, Adolfsson, Jan5, Van Hemelrijck, Mieke1
Publikováno v:
PLoS ONE. 4/12/2018, Vol. 13 Issue 4, p1-10. 10p.
Autor:
Dettorre, Gino M., Dolly, Saoirse, Loizidou, Angela, Chester, John, Jackson, Amanda, Mukherjee, Uma, Zambelli, Alberto, Aguilar Company, Juan, Bower, Mark, Sng, Christopher C. T., Salazar Soler, Ramón, Bertuzzi, Alexia, Brunet, Joan, Mesia, Ricard, Sita-Lumsden, Ailsa, Seguí, Elia, Biello, Federica, Generali, Daniele, Grisanti, Salvatore, Seeva, Pavetha, Rizzo, Gianpiero, Libertini, Michela, Maconi, Antonio, Moss, Charlotte, Russell, Beth, Harbeck, Nadia, Vincenzi, Bruno, Bertulli, Rossella, Ottaviani, Diego, Liñan, Raquel, Marrari, Andrea, Carmona García, M. Carmen, Chopra, Neha, Tondini, Carlo Alberto, Mirallas, Oriol, Tovazzi, Valeria, Fotia, Vittoria, Cruz, Claudia Andrea, Saoudi González, Nadia, Felip, Eudald, Roqué, Ariadna, Lee, Alvin J. X., Newsom-Davis, Tom, García Illescas, David, Reyes, Roxana, Wong, Yien Ning Sophia, Ferrante, Daniela, Scotti, Lorenza, Marco Hernández, Javier, Ruiz Camps, Isabel, Patriarca, Andrea, Rimassa, Lorenza, Chiudinelli, Lorenzo, Franchi, Michela, Santoro, Armando, Prat Aparicio, Aleix, Gennari, Alessandra, Van Hemelrijck, Mieke, Tabernero Caturla, Josep, Diamantis, Nikolaos, Pinato, David J., OnCovid study group
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Scientia
Universidad de Barcelona
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Scientia
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Inflamació; Mediadors d'inflamació Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Inflamación; Mediadores de la inflamación Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Inflammation; Inflammation mediato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38b479d72020cc81746269413907119b
http://hdl.handle.net/2445/176045
http://hdl.handle.net/2445/176045
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jan Adolfsson, Pär Stattin, Beth Russell, Kerri Beckmann, Christel Häggström, Hans Garmo, Mieke Van Hemelrijck, Lars Holmberg, Debra H. Josephs
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancer
Beckmann, K, Russell, B, Josephs, D, Garmo, H, Häggström, C, Holmberg, L, Stattin, P, Van Hemelrijck, M & Adolfsson, J 2019, ' Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer : a population-based case-control study ', BMC Cancer .
BMC Cancer
Beckmann, K, Russell, B, Josephs, D, Garmo, H, Häggström, C, Holmberg, L, Stattin, P, Van Hemelrijck, M & Adolfsson, J 2019, ' Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer : a population-based case-control study ', BMC Cancer .
Background Whether chronic inflammation increases prostate cancer risk remains unclear. This study investigated whether chronic inflammatory diseases (CID) or anti-inflammatory medication use (AIM) were associated with prostate cancer risk. Methods F
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195690 (2018)
PLoS ONE
PLoS ONE
Objectives To investigate the association between lower urinary-tract infections, their associated antibiotics and the subsequent risk of developing PCa. Subjects/Patients (or materials) and methods Using data from the Swedish PCBaSe 3.0, we performe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fab3384d4b42d55ad52401041e7a0c0
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-352474
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-352474